The effects of a brief CBT intervention, delivered by frontline mental health staff, to promote recovery in people with psychosis and comorbid anxiety or depression (the GOALS study): study protocol for a randomized controlled trial

Helen Waller, Tom Craig, Sabine Landau, Miriam Fornells-Ambrojo, Nedah Hassanali, Catherine Iredale, Suzanne Jolley, Paul McCrone, Philippa Garety, Helen Waller, Tom Craig, Sabine Landau, Miriam Fornells-Ambrojo, Nedah Hassanali, Catherine Iredale, Suzanne Jolley, Paul McCrone, Philippa Garety

Abstract

Background: NICE guidance states that cognitive behavioural therapy (CBT) should be offered to all patients with psychosis. However, there is a need to improve access to therapeutic interventions. We aim to train frontline mental health staff to deliver brief, structured CBT-based therapies. We have developed and piloted a manualized intervention to support people with psychosis and anxious avoidance or depression to work towards a personal recovery goal.

Methods/design: The 'GOALS Study' is a pilot randomized controlled trial comparing usual care plus an 8-week intervention with usual care alone. The key objective is to assess clinical feasibility (recruitment and randomization; compliance with the treatment manual; acceptability and satisfaction; progress towards goals). A secondary objective is a preliminary evaluation of efficacy. Sixty-six participants with a diagnosis of psychosis, plus symptoms of depression or anxiety will be recruited from adult mental health services. Those currently refusing medication, in receipt of CBT, or with a primary diagnosis of an organic mental health problem or substance dependency will be excluded. Following informed consent, randomization will be independent of the trial team, at a 50:50 ratio, at the level of the individual and stratified by main problem focus. Following randomization, participants allocated to the intervention group will begin the 8-week intervention with a local, trained member of staff, supervised by the study coordinator. Outcomes will be assessed blind to treatment condition at 0, 12 and 18 weeks post-randomization. The primary outcome measure for the efficacy analysis will be activity levels at 12 weeks. Secondary outcome measures include mood, psychotic symptoms, quality of life and clinical distress. A health economic analysis comparing service use in each condition will also be performed. Recruitment began in March, 2013 and is ongoing until December, 2014.

Discussion: This is the first trial of the GOALS intervention. The approach is brief and staff can be readily trained in its delivery: there is therefore potential to develop a cost-effective intervention that could be widely disseminated. If the trial proves clinically feasible and demonstrates preliminary evidence of efficacy, a large multi-site trial will be warranted.

Trial registration: Current Controlled Trials

Isrctn: 73188383. http://public.ukcrn.org.uk/search/StudyDetail.aspx?StudyID=13538.

Figures

Figure 1
Figure 1
Study flowchart.

References

    1. Garety PA, Kuipers E, Fowler D, Freeman D, Bebbington PE. A cognitive model of the positive symptoms of psychosis. Psychol Med. 2001;31:189–195.
    1. Slade T, Johnston A, Oakley Browne MA, Andrews G, Whiteford H. National survey of mental health and wellbeing: methods and key findings. Aust N Z J Psychiatry. 2007;2009(43):594–605.
    1. Buckley PF, Miller BJ, Lehrer DS, Castle DJ. Psychiatric comorbidities and schizophrenia. Schizophr Bull. 2009;35:383–402.
    1. Achim AM, Maziade M, Raymond É, Olivier D, Mérette C, Roy MA. How prevalent are anxiety disorders in schizophrenia? A meta-analysis and critical review on a significant association. Schizophr Bull. 2011;37:811–821.
    1. National Institute for Health and Care Excellence. Core Interventions in the Treatment and Management of Schizophrenia in Primary and Secondary Care (update) London: National Institute for Health and Care Excellence; 2009.
    1. Wykes T, Steel C, Everitt B, Tarrier N. Cognitive behavior therapy for schizophrenia: effect sizes, clinical models, and methodological rigor. Schizophr Bull. 2008;34:523–537.
    1. National Institute for Health and Care Excellence. Psychosis and Schizophrenia in Adults: Treatment and Management. London: National Institute for Health and Care Excellence; 2014.
    1. Fowler D, Hodgekins J, Painter M, Reilly T, Crane C, Macmillan I, Jones PB. Cognitive behaviour therapy for improving social recovery in psychosis: a report from the ISREP MRC Trial Platform study (Improving Social Recovery in Early Psychosis) Psychol Med. 2009;39:1627.
    1. Mazzucchelli T, Kane R, Rees C. Behavioral activation treatments for depression in adults: a meta-analysis and review. Clin Psychol Sci Pract. 2009;16:383–411.
    1. Mattick RP, Peters L, Clarke JC. Exposure and cognitive restructuring for social phobia: a controlled study. Behav Ther. 1990;20:3–23.
    1. Wolitzky-Taylor KB, Horowitz JD, Powers MB, Telch MJ. Psychological approaches in the treatment of specific phobias: a meta-analysis. Clin Psychol Rev. 2008;28:1021–1037.
    1. Mairs H, Lovell K, Campbell M, Keeley P. Development and pilot investigation of behavioral activation for negative symptoms. Behav Modif. 2011;35:486–506.
    1. Lejuez CW, Hopko DR, Acierno R, Daughters SB, Pagoto SL. Ten year revision of the brief behavioral activation treatment for depression: revised treatment manual. Behav Modif. 2011;35:111–161.
    1. Ekers D, Richards D, McMillan D, Bland JM, Gilbody S. Behavioural activation delivered by the non-specialist: phase II randomised controlled trial. Br J Psychiatry. 2011;198:66–72.
    1. Waller H, Garety PA, Jolley S, Fornells-Ambrojo M, Kuipers E, Onwumere J, Woodall A, Emsley R, Craig T. Low intensity cognitive behavioural therapy for psychosis: a pilot study. J Behav Ther Exp Psychiatry. 2012;44:98–104.
    1. Waller H, Garety P, Jolley S, Fornells-Ambrojo M, Kuipers E, Onwumere J, Woodall A, Craig T. Training frontline mental health staff to deliver ‘low intensity’ psychological therapy for psychosis: a qualitative analysis of therapist and service user views on the therapy and its future implementation. Behav Cogn Psychother. 2013. .
    1. Snaith RP. The Hospital Anxiety and Depression Scale. Health Qual Life Outcomes. 2003;1:29.
    1. Jolley S, Garety P, Dunn G, White J, Aitken M, Challacombe F, Griggs M, Wallace M, Craig T. A pilot validation study of a new measure of activity in psychosis. Soc Psychiatry Psychiatr Epidemiol. 2005;40:905–911.
    1. Jolley S, Garety PA, Ellet L, Kuipers E, Freeman D, Bebbington PE, Fowler DG, Dunn G. A validation of a new measure of activity in psychosis. Schizophr Res. 2006;85:288–95.
    1. Killaspy H, Cook S, Mundy T, Craig T, Holloway F, Leavey G, Marston L, McCrone P, Koeser L, Arbuthnott M, Omar RZ, King M. Study protocol: cluster randomised controlled trial to assess the clinical and cost effectiveness of a staff training intervention in inpatient mental health rehabilitation units in increasing service users’ engagement in activities. BMC Psychiatry. 2013;13:216.
    1. Kay SR, Fiszbein A, Opler LA. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13:261–76.
    1. Haddock G, McCarron J, Tarrier N, Faragher EB. Scales to measure dimensions of hallucinations and delusions: the Psychotic Symptom Rating Scales (PSYRATS) Psychol Med. 1999;29:879–89.
    1. Chambless DL, Caputo GC, Jasin SE, Gracely EJ, Williams C. The Mobility Inventory for agoraphobia. Behav Res Ther. 1985;23:35–44.
    1. Tennant R, Hiller L, Fishwick R, Platt S, Joseph S, Weich S, Parkinson J, Secker J, Stewart-Brown S. The Warwick-Edinburgh mental well-being scale (WEMWBS): development and UK validation. Health Qual Life Outcomes. 2007;5:63.
    1. Priebe S, Huxley P, Knight S, Evans S. Application and results of the Manchester Short Assessment of Quality of Life (MANSA) Int J Soc Psychiatry. 1999;45:7–12.
    1. Barkham M, Bewick B, Mullin T, Gilbody S, Connell J, Cahill J, Evans C. The CORE-10: a short measure of psychological distress for routine use in the psychological therapies. Couns Psychother Res. 2013;13:3–13.
    1. Chisholm D, Knapp MRJ, Knudsen HC, Amaddeo F, Gaite L, Van Wijngaarden B. Epsilon Study Group. Client socio-demographic and service receipt inventory - European version: development of an instrument for international research. B J Psychiatry Suppl. 2000;177:s28–s33.
    1. Bond A, Lader M. The use of analogue scales in rating subjective feelings. Br J Med Psychol. 1974;47:211–218.
    1. Decker SE, Nich C, Carroll KM, Martino S. Development of the Therapist Empathy Scale. Behav Cogn Psychother. 2014;42:339–354.
    1. Dunn G, Maracy M, Dowrick C, Ayuso-Mateos JL, Dalgard OS, Page H, Lehtinen V, Casey P, Wilkinson C, Vazquez-Barquero JL, Wilkinson G. the ODIN group. Estimating psychological treatment effects from a randomised controlled trial with both non-compliance and loss to follow-up. Br J Psychiatry. 2003;183:323–331.
    1. Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3:77–101.
    1. Garety PA, Fowler DG, Freeman D, Bebbington P, Dunn G, Kuipers E. Cognitive-behavioural therapy and family intervention for relapse prevention and symptom reduction in psychosis: randomised controlled trial. Br J Psychiatry. 2008;192:412–23.
    1. Prytys M, Garety PA, Jolley S, Onwumere J, Craig T. Implementing the NICE guideline for schizophrenia recommendations for psychological therapies: a qualitative analysis of the attitudes of CMHT staff. Clin Psychol Psychother. 2011;18:48–59.

Source: PubMed

スポンサーと協力者

医学的状態

薬物療法

3
購読する